Cargando…
Recent advances in the path toward the cure for chronic myeloid leukemia
Through the phase 3 International Randomized Study of Interferon vs. STI571 (IRIS) trial, imatinib emerged as the standard treatment for chronic myeloid leukemia (CML) and has successfully prolonged the duration of both the chronic phase (CP) and the disease-free state. The majority of newly diagnos...
Autor principal: | Kim, Dong-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208199/ https://www.ncbi.nlm.nih.gov/pubmed/22065971 http://dx.doi.org/10.5045/kjh.2011.46.3.169 |
Ejemplares similares
-
Recent advances in the treatment of acute myeloid leukemia
por: Abdel-Wahab, Omar, et al.
Publicado: (2010) -
Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
por: Cumbo, Cosimo, et al.
Publicado: (2020) -
Recent advances in understanding chronic myeloid leukemia: where do we stand?
por: Kumar, Rahul, et al.
Publicado: (2021) -
Recent advances in the understanding and treatment of acute myeloid leukemia
por: Watts, Justin, et al.
Publicado: (2018) -
Recent advances in targeted therapies in acute myeloid leukemia
por: Bhansali, Rahul S., et al.
Publicado: (2023)